Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety, Toxicity and MTD of One Intravenous IV Injection of Donor CTLs Specific for CMV and Adenovirus (ACT-CAT)
This study is currently recruiting participants.
Verified April 2013 by Baylor College of Medicine
Study NCT00880789   Information provided by Baylor College of Medicine

First Received on April 13, 2009.   Last Updated on April 30, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cytomegalovirus Infection
Adenovirus Infection
Additional conditions recognized in this trial
Adenoviridae Infections
Cytomegalovirus Infections
More general conditions related to this trial
DNA Virus Infections
Herpesviridae Infections
Virus Diseases
Interventions listed in this trial
Dose Escalation Comparison
Sponsors listed in this trial
Baylor College of Medicine
Texas Children's Hospital
The Methodist Hospital System
Center for Cell and Gene Therapy, Baylor College of Medicine


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services